Hydroxychloroquine study row: Here's everything you should know
ET's Divya Rajagopal takes a look at the chain of events that led to the latest row about hydroxychloroquine - the drug that has left the global medical fraternity divided.
READ MORE:
Other Biotech Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
USV | Take heart: Steering preventive strategies for charting a journey towards cardiac wellness
Beat Diabetes With Lifestyle Modification
Serum to double investment in Biocon's unit to $300 mn; aim to generate higher EBITDA going ahead: Kiran Mazumdar-Shaw
India is stepping up genome sequencing of COVID 19 positive samples amid growing outbreaks in China, Japan and South Korea
